TGFB1 and neoplasm: Manipulated TAMs thus gain secretion of various tumor-promoting factors including CCL18, IL-10, and TGF-β while inhibiting the release of cytotoxic factors like IL-2, IL-12, TNF-α, and IFN-γ, impeding the anti-tumor capacity of other immune components and prolong tumor survival (115).